Adaptive Biotechnologies
ADPT
ADPT
117 hedge funds and large institutions have $2.5B invested in Adaptive Biotechnologies in 2019 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.62% more ownership
Funds ownership: 64.67% → 65.29% (+0.62%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
33% less capital invested
Capital invested by funds: $3.74B → $2.5B (-$1.24B)
Holders
117
Holding in Top 10
4
Calls
$4.78M
Puts
$3.02M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$38.2M | |
| 3 | +$34.5M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$20.1M |
| 5 |
FAM
Fred Alger Management
New York
|
+$18.2M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$13.8M | |
| 3 | -$12.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$12M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$9.66M |